Oct 23, 2024 / 12:00PM GMT
Operator
Good morning and welcome to the Boston Scientific Third Quarter 2024 earnings call. All participants will b
in listen only mode. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to John Munson, Senior Vice President, Investor Relations. Please go ahead.
John Sununu - Boston Scientific Corp - Independent Director
Thanks, Joe, and thanks, everyone, for joining us. With me today are Mike Mahoney, Chairman and Chief Executive Officer, and Dan Brennan, Executive Vice President and Chief Financial Officer. Joining the Q&A session. Mike and Dan will be joined by our Chief Medical Officer, Dr. Ken Stein, our Co-Founder, President of our MedSurg and Asia Pacific businesses. We issued a press release earlier this morning announcing our Q3 results, which included reconciliations of non-GAAP measures used in this release. The release as well as reconciliations of non-GAAP measures used in today's call. Please note on the call. Operational revenue excludes the impact of foreign currency fluctuations
Q3 2024 Boston Scientific Corp Earnings Call Transcript
Oct 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers